142 related articles for article (PubMed ID: 22721860)
21. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5.
Zhou M; Guo Y; Zhao J; Hu Q; Hu Y; Zhang A; Chen H; Jin M
Vaccine; 2009 Aug; 27(38):5271-7. PubMed ID: 19576561
[TBL] [Abstract][Full Text] [Related]
22. Field evaluation of the efficacy, compatibility and serologic profiling of a combined vaccine against porcine reproductive and respiratory syndrome and Haemophilus parasuis in nursery pigs.
Palzer A; Eddicks M; Zoels S; Stark J; Reese S; Strutzberg-Minder K; Fiebig K; Ritzmann M
Prev Vet Med; 2015 May; 119(3-4):134-40. PubMed ID: 25819628
[TBL] [Abstract][Full Text] [Related]
23. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
Hau SJ; Eberle KC; Brockmeier SL
Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
[TBL] [Abstract][Full Text] [Related]
24. Virulence, transmission, and heterologous protection of four isolates of Haemophilus parasuis.
Brockmeier SL; Loving CL; Mullins MA; Register KB; Nicholson TL; Wiseman BS; Baker RB; Kehrli ME
Clin Vaccine Immunol; 2013 Sep; 20(9):1466-72. PubMed ID: 23885030
[TBL] [Abstract][Full Text] [Related]
25. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention.
Li M; Li C; Song S; Kang H; Yang D; Li G
Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.
Álvarez-Estrada Á; Gutiérrez-Martín CB; Rodríguez-Ferri EF; Martínez-Martínez S
BMC Vet Res; 2018 Nov; 14(1):326. PubMed ID: 30400794
[TBL] [Abstract][Full Text] [Related]
27. The effect of a homologous bacterin given to sows prefarrowing on the development of Glässer's disease in postweaning pigs after i.v. challenge with Haemophilus parasuis serotype 5.
Hoffmann CR; Bilkei G
Dtsch Tierarztl Wochenschr; 2002 Jun; 109(6):271-6. PubMed ID: 12125173
[TBL] [Abstract][Full Text] [Related]
28. Immune response to oligopeptide permease A (OppA) protein in pigs naturally and experimentally infected with Haemophilus parasuis.
Macedo N; Oliveira S; Torremorell M; Rovira A
Res Vet Sci; 2016 Aug; 107():62-67. PubMed ID: 27473976
[TBL] [Abstract][Full Text] [Related]
29. Sow vaccination modulates the colonization of piglets by Haemophilus parasuis.
Cerdà-Cuéllar M; Naranjo JF; Verge A; Nofrarías M; Cortey M; Olvera A; Segalés J; Aragon V
Vet Microbiol; 2010 Oct; 145(3-4):315-20. PubMed ID: 20447775
[TBL] [Abstract][Full Text] [Related]
30. Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response.
Macedo N; Cheeran MC; Rovira A; Holtcamp A; Torremorell M
Vet Microbiol; 2017 Feb; 199():91-99. PubMed ID: 28110792
[TBL] [Abstract][Full Text] [Related]
31. Vaccination of gnotobiotic primary specific pathogen-free pigs against Haemophilus parasuis.
Miniats OP; Smart NL; Ewert E
Can J Vet Res; 1991 Jan; 55(1):33-6. PubMed ID: 1832078
[TBL] [Abstract][Full Text] [Related]
32. Cross protection among Haemophilus parasuis strains in immunized gnotobiotic pigs.
Miniats OP; Smart NL; Rosendal S
Can J Vet Res; 1991 Jan; 55(1):37-41. PubMed ID: 1884282
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of lungs from pigs immunized with a mutant transferrin binding protein B-based vaccine and challenged with Haemophilus parasuis.
Martínez-Martínez S; Rodríguez-Ferri EF; Frandoloso R; Garrido-Pavón JJ; Zaldívar-López S; Barreiro C; Gutiérrez-Martín CB
Comp Immunol Microbiol Infect Dis; 2016 Oct; 48():69-78. PubMed ID: 27638122
[TBL] [Abstract][Full Text] [Related]
34. First comparison of adjuvant for trivalent inactivated Haemophilus parasuis serovars 4, 5 and 12 vaccines against Glässer's disease.
Xue Q; Zhao Z; Liu H; Chen K; Xue Y; Wang L
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):153-8. PubMed ID: 26672914
[TBL] [Abstract][Full Text] [Related]
35. Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5.
Li M; Song S; Yang D; Li C; Li G
Vaccine; 2015 Mar; 33(14):1695-701. PubMed ID: 25704800
[TBL] [Abstract][Full Text] [Related]
36. Analysis of efficacy obtained with a trivalent inactivated
Zhao Z; Liu H; Xue Y; Chen K; Liu Z; Xue Q; Wang C
Can J Vet Res; 2017 Jan; 81(1):22-27. PubMed ID: 28154458
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel Haemophilus parasuis serovar 5 vaccine candidates using an immunoproteomic approach.
Li G; Xie F; Li J; Liu J; Li D; Zhang Y; Langford PR; Li Y; Liu S; Wang C
J Proteomics; 2017 Jun; 163():111-117. PubMed ID: 28528009
[TBL] [Abstract][Full Text] [Related]
38. Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice.
Fu S; Zhang M; Ou J; Liu H; Tan C; Liu J; Chen H; Bei W
Vaccine; 2012 Nov; 30(48):6839-44. PubMed ID: 23000128
[TBL] [Abstract][Full Text] [Related]
39. Haemophilus parasuis vaccines.
Liu H; Xue Q; Zeng Q; Zhao Z
Vet Immunol Immunopathol; 2016 Nov; 180():53-58. PubMed ID: 27692096
[TBL] [Abstract][Full Text] [Related]
40. Changes in macrophage phenotype after infection of pigs with Haemophilus parasuis strains with different levels of virulence.
Costa-Hurtado M; Olvera A; Martinez-Moliner V; Galofré-Milà N; Martínez P; Dominguez J; Aragon V
Infect Immun; 2013 Jul; 81(7):2327-33. PubMed ID: 23589574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
